ArticleThe Lancet regional health. Southeast Asia2023
Overstated conclusions of a non-inferiority trial testing immunogenicity and safety of homologous and heterologous booster - authors' reply.
Winsley Rose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.